Alterity gains positive FDA feedback ahead of phase III MSA trial

Alterity Therapeutics receives positive feedback following a Type C Meeting with the US Food and Drug Administration regarding its planned ... Read More The post Alterity gains positive FDA feedback ahead of phase III MSA trial appeared first on Stockhead .

Go to News Site